In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Izabella Dudek-Urbanowicz, managing director of Patpol, among the 80 most influential women in the IP world

The rankings of the most influential women in the IP world has been prepared for Czytaj dalej

Playing with WOŚP – With Heart and Sustainability

Every year, we proudly join forces with the Great Orchestra of Christmas Charity (WOŚP) – Czytaj dalej

Surname, first name, pseudonym, personal image ? can they be regisrtered as a trademark in the Polish Patent Office or EUIPO?

Author: Agnieszka Skrzypczak On 24 March 2016 a Spanish company, Gaudí BCN Projects S.L., filed Czytaj dalej